ALK and neoplasm: On the other hand, the simultaneous administration of crizotinib and α-tocopherol significantly attenuated the inhibitory effects of crizotinib on tumor formation and enlargements in the liver and lymph nodes in mice receiving Ba/F3 cells expressing NPM-ALK (Fig 6B).